Skip to content Skip to left sidebar Skip to right sidebar Skip to footer

Health

Pink Power Run 3.0 Announced in Hyderabad to Raise Breast Cancer Awareness

The Sudha Reddy Foundation and the MEIL Foundation have jointly announced the third edition of Pink Power Run, an international half-marathon and community fitness initiative aimed at raising critical awareness about breast cancer. Scheduled for September 27, 2026, in Hyderabad, this highly anticipated event is expected to draw more than 20,000 participants from across the globe.

Event Details and Categories

The Pink Power Run 3.0 will feature a professionally certified 21.097-km half-marathon recognized by the Association of International Marathons and Distance Races (AIMS). To accommodate runners of all fitness levels, the event will also offer:

  • 10-km run
  • 5-km run
  • 3-km fun run

With a substantial total prize pool of Rs 75 lakh and awards for over 100 winners, the upgraded format is designed to attract leading distance runners and international athletes, elevating the event to a world-class sporting spectacle.

More Than Just a Race: A Movement for Health

At the announcement press conference, Sudha Reddy, Founder of the Sudha Reddy Foundation and Director of MEIL, emphasized that the Pink Power Run transcends traditional sporting events.

“The Pink Power Run was intended to go beyond being a sporting event and serve as a reminder of the importance of fitness, preventive healthcare, and early action,” said Sudha Reddy.

Emphasizing the timeless adage that “Health is Wealth,” she noted that a healthy community forms the foundation for creating a stronger, more vibrant economy. The initiative aims to promote overall health while driving critical awareness around breast cancer prevention and early detection.

The Urgent Need: Telangana’s Breast Cancer Crisis

The event’s timing and mission are particularly critical given the current healthcare landscape. Dr. Pragnya Chigurupati, a breast oncosurgeon with 10 years of experience, highlighted alarming statistics at the press conference.

“Telangana currently records the highest incidence of breast cancer cases in the country,” Dr. Chigurupati revealed, stressing the urgent need to expand awareness efforts, particularly across rural and semi-urban areas where access to early detection resources remains limited.

She emphasized that proactive prevention through regular health check-ups is the most vital tool in saving lives, underlining the broader health factors associated with breast cancer.

Miss World 2025 Lends Support

Adding international prestige to the event, Miss World 2025 Opal Suchata Chuangsri graced the announcement ceremony. She called breast cancer awareness a “deeply important cause” that requires strong, driving initiatives like the Pink Power Run to build a healthier community.

“Participating in and supporting the marathon plays a vital role in instilling a lasting sense of health awareness among both the runners and the broader public,” Opal Suchata Chuangsri stated.

Innovative Social Impact: Miles for Mammograms

One of the most inspiring aspects of Pink Power Run 3.0 is its innovative “Miles for Mammograms” initiative, launched in partnership with AIG Hospitals.

Under this groundbreaking program:

  • The cumulative distance covered by all participants will be converted into medical diagnostic support for underprivileged patients.
  • For every 100 km collectively completed, the Sudha Reddy Foundation will sponsor:
    • One free breast cancer screening
    • One free mammogram test

This unique initiative ensures that every step taken by runners directly translates into life-saving healthcare access for those who need it most.

Strategic Impact: Building a Healthier India

The Pink Power Run 3.0 represents a powerful convergence of:

  1. Sports and Fitness: Encouraging physical activity and healthy lifestyles
  2. Healthcare Awareness: Educating the public about breast cancer prevention and early detection
  3. Social Responsibility: Providing free diagnostic services to underprivileged communities
  4. Community Building: Bringing together thousands of individuals for a common cause

Looking Ahead

As Hyderabad prepares to host this momentous event on September 27, the Pink Power Run 3.0 stands as a testament to the power of collective action in addressing critical health challenges. By combining athletic excellence with social impact, the initiative is setting a new benchmark for how sporting events can drive meaningful change.

Whether you’re a professional runner, a fitness enthusiast, or simply someone who believes in the cause, Pink Power Run 3.0 offers an opportunity to be part of something bigger—a movement toward a healthier, more aware, and empowered India.

For Participation and Registration:

Interested participants are encouraged to register early to secure their spot in this transformative event. Together, every kilometer run brings us closer to a future where breast cancer is detected early, treated effectively, and ultimately prevented.

Advanced TPS Technology for Alzheimer’s and Dementia Now Available in India

A revolutionary non-invasive brain stimulation technology is bringing fresh hope to millions of Indian families battling Alzheimer’s disease and dementia. Transcranial Pulse Stimulation (TPS), an advanced neuromodulation technology that uses short ultrasound pulses to stimulate targeted brain areas, is now available in India for the first time at Solaceum in Madhapur, Hyderabad.

What is Transcranial Pulse Stimulation (TPS)?

TPS represents a groundbreaking advancement in non-invasive neuromodulation. This cutting-edge technology delivers short ultrasound pulses through the skull to precisely targeted regions of the brain, offering a potential therapeutic avenue for patients with Alzheimer’s disease and cognitive impairment.

Key Features of TPS Technology:

  • Completely Non-Invasive: No surgery or electrode implantation required
  • Precision Targeting: Utilizes MRI-based neuronavigation to identify and stimulate specific brain areas
  • European Innovation: Developed in Europe with CE marking approval
  • Emerging Clinical Evidence: Early research shows encouraging findings in cognitive and functional outcomes

Solaceum: India’s First TPS Center

Solaceum Centre for Advanced Pain Management, Neurorehabilitation & Neuromodulation has become the first and only center in India to offer TPS as a clinical service, bringing this emerging European technology to Indian patients under specialist neurological care.

The center is led by Dr. Sreekanth Vemula, a highly qualified neurologist with credentials from prestigious institutions including AIIMS and PGIMER. As Founder and Chairman of Solaceum, Dr. Vemula is spearheading the initiative to make advanced neuromodulation technologies accessible to Indian patients.

“Alzheimer’s disease and dementia remain significant challenges for patients, families and clinicians. There is a growing need to explore innovative and non-invasive approaches that may complement existing neurological care. Technologies such as TPS are generating scientific interest because of their non-invasive nature and emerging clinical evidence,” said Dr. Sreekanth Vemula.

International Expertise Comes to Hyderabad

To ensure scientific rigor and proper understanding of this technology, Solaceum recently hosted a comprehensive scientific session on TPS for neurologists and psychiatrists in Hyderabad, in partnership with Storz Medical AG, Switzerland.

The program featured Prof. Dr. Ulrich Sprick, Medical Director and Head of the Department of Dayclinics and Out-Patients at Alexius/Josef Clinic, Neuss, Germany, and Associate Professor at the Medical Faculty of the University of Düsseldorf.

Prof. Sprick shared his extensive international experience with TPS, discussing:

  • Proposed mechanisms of action
  • Clinical applications in neurological conditions
  • Current scientific evidence and research findings
  • International best practices in TPS administration

This knowledge transfer initiative provided Indian medical professionals with valuable insights into how TPS is being utilized globally and its potential role in the evolving field of non-invasive neuromodulation.

Why TPS Matters for Indian Patients

The Growing Challenge of Alzheimer’s and Dementia

Alzheimer’s disease and dementia represent one of the most significant healthcare challenges facing India’s aging population. These progressive neurological conditions affect not only patients but also place immense emotional, physical, and financial burdens on families and caregivers.

The Need for Non-Invasive Solutions

Traditional treatment approaches for Alzheimer’s have primarily focused on medication management. However, there is a growing recognition of the need for innovative, non-invasive technologies that can complement existing care and potentially improve cognitive and functional outcomes.

TPS: A Promising New Avenue

TPS offers several advantages that make it particularly attractive for the Indian healthcare landscape:

  • Safety Profile: Non-invasive nature reduces risks associated with surgical interventions
  • Accessibility: Outpatient-based treatment eliminates need for hospitalization
  • Complementary Approach: Can be integrated with existing treatment protocols
  • Patient-Centered: Personalized treatment based on individual neurological assessment

Evidence-Based Approach to Innovation

Dr. Vemula emphasizes Solaceum’s commitment to scientific evidence and appropriate patient selection:

“At Solaceum, our objective is to make contemporary neuromodulation technologies accessible to Indian patients while ensuring that their use is guided by scientific evidence, specialist assessment and appropriate patient selection.”

This evidence-based approach is crucial as the medical community continues to evaluate TPS through ongoing clinical research and long-term studies to determine its precise role in Alzheimer’s disease and other neurological disorders.

Comprehensive Care at Solaceum

Beyond TPS, Solaceum offers a comprehensive range of advanced neurological and pain management services:

Neuromodulation & Brain Stimulation:

  • Transcranial Pulse Stimulation (TPS)
  • Repetitive Transcranial Magnetic Stimulation (rTMS)
  • Other advanced neuromodulation approaches

Neurorehabilitation:

  • Stroke rehabilitation
  • Parkinson’s disease rehabilitation
  • Spasticity management
  • Cognitive and neurological rehabilitation

Advanced Pain Management:

  • Chronic and neuropathic pain
  • Sports-related injuries
  • Complex Regional Pain Syndrome (CRPS)
  • Joint and musculoskeletal pain

The center combines specialist neurological evaluation with contemporary technologies and multidisciplinary rehabilitation to provide personalized treatment plans focused on improving function and quality of life.

Looking Ahead: The Future of Alzheimer’s Care in India

The introduction of TPS in India marks a significant milestone in the country’s neurological care landscape. While Alzheimer’s disease remains a complex and progressive condition with no definitive cure, technologies like TPS represent hope for improved quality of life and potentially better cognitive outcomes.

As clinical research continues to evolve and long-term evidence accumulates, TPS may play an increasingly important role in the comprehensive management of Alzheimer’s disease and other cognitive disorders.

For patients and families in India who have been searching for innovative treatment options, the availability of TPS at Solaceum represents a new chapter in the fight against Alzheimer’s and dementia—one defined by hope, innovation, and the promise of better possibilities.

For Appointments and Information:

Solaceum Centre of Excellence
📍 3rd & 4th Floor, Vijaya Diagnostic Centre, Hitech City Road, Madhapur, Hyderabad 500081
📞 +91 89776 30120
[email protected]

Two-Month-Old Undergoes Robotic Surgery at Hyderabad Hospital

Hyderabad: A two-month-old infant has become one of the youngest patients in India to undergo a robot-assisted surgical procedure, with doctors at Citizens Specialty Hospital in Nallagandla, Hyderabad, successfully performing a robotic pyeloplasty.

The minimally invasive procedure was carried out by Prabhu Karunakaran, consultant paediatric urologist, to correct a condition affecting the infant’s kidney and ureter and restore normal urine flow.

The robotic procedure was performed instead of conventional open surgery, allowing the medical team to treat the condition through a minimally invasive approach. The baby recovered well and was discharged just two days after the operation.

The procedure adds to Citizens Specialty Hospital’s experience in paediatric robotic surgery. In 2023, Mallikarjuna Reddy performed robotic surgery on a 21-day-old infant, marking another significant milestone involving one of the youngest paediatric patients in the region. The two procedures were performed by different specialists.

Robotic-assisted pyeloplasty can offer several advantages over conventional open surgery, including smaller incisions, reduced blood loss, less postoperative pain and faster recovery. Such benefits can be particularly significant for infants and young children.

The successful surgery highlights the growing use of advanced robotic and minimally invasive techniques in paediatric urology and reflects the expanding capabilities of Hyderabad’s healthcare sector in specialised surgical care.

Amgen to Establish New Science and Innovation Centre in Hyderabad’s Genome Valley

Global biopharmaceutical giant Amgen is doubling down on its commitment to India, announcing plans to open a state-of-the-art Science and Innovation Centre in Hyderabad’s premier Genome Valley. Slated to become operational in 2027, this new facility will mark a significant expansion of Amgen’s global research and development (R&D) network, which currently comprises seven research laboratories worldwide.

Bridging Wet-Lab Science and Digital Innovation

The new Hyderabad centre is designed to be a powerhouse of discovery. It will focus on critical, high-impact areas including:

  • Discovery Chemistry
  • Drug Metabolism and Pharmacokinetics (DMPK)
  • Precision Medicine
  • Data Science and Digital Technologies

By integrating experimental “wet-lab” science with advanced data analytics and AI-driven tools, the centre aims to dramatically accelerate the discovery and development of life-saving medicines. This facility will seamlessly complement Amgen’s existing Global Capability Centre (GCC) in Hyderabad, creating a powerful synergy between digital innovation and hands-on biological research.

Why Hyderabad? A Thriving Life Sciences Ecosystem

Hyderabad has long been recognized as India’s “Genome Valley,” but this new investment signals a shift from manufacturing and clinical research to high-value, early-stage discovery.

D. Sridhar Babu, Telangana’s Minister for IT and Industries, praised the decision, highlighting the state’s robust ecosystem: “Hyderabad brings together scientific talent, technology, and industry at scale and has built one of the world’s strongest life sciences ecosystems, with deep capabilities in pharmaceuticals and vaccines. The next chapter is about taking that strength into discovery and innovation. Our ambition is to make Hyderabad a place where the next generation of medicines and therapies can be discovered, developed, and taken to the world.”

Leadership Perspectives on Global Integration

For Amgen, this move is about creating a truly interconnected global R&D footprint.

Jay Bradner, Executive Vice President of Research and Development, Artificial Intelligence, and Data at Amgen, noted that the Genome Valley centre will perfectly complement the company’s strong US-based R&D operations. It will expand Amgen’s ability to connect science, data, and technology across its global research system, translating complex insights into tangible new medicines.

Som Chattopadhyay, Senior Vice President of Global Business Solutions and National Executive at Amgen, emphasized that this development firmly establishes India as a critical, strategic pillar in Amgen’s global R&D network.

Echoing this sentiment, Naveen Gullapalli, Managing Director of Amgen India, highlighted the region’s human capital: “Hyderabad’s STEM talent and life sciences ecosystem will support advanced technologies at scale. Our new centre at Genome Valley will help integrate biotechnology and digital innovation to serve more patients globally.”

Looking Ahead

Amgen’s investment in Hyderabad is a resounding vote of confidence in India’s scientific prowess and its potential to drive global healthcare innovation. As the centre gears up for its 2027 launch, it promises to create high-value jobs, foster cutting-edge research, and cement Hyderabad’s status as a premier global destination for biotech discovery and digital health innovation.

The future of medicine is being written in Hyderabad, and Amgen is ready to lead the next chapter.

Organ Donation Miracle: Two Hyderabad Families Give Life to 7 Patients

In the darkest moments of grief, humanity has the power to shine its brightest. In a deeply moving display of altruism and courage, two families in Hyderabad have transformed unimaginable personal tragedy into a beacon of hope, donating the organs of their brain-dead loved ones to save the lives of seven critically ill patients.

These selfless acts serve as a profound reminder that even in loss, the ultimate gift of life can endure.

The First Hero: A Mother’s Final Gift

Burela Seethamma, a 63-year-old housewife from Guntur, was a beloved pillar of her family. On July 12, she suffered a sudden and severe spike in blood pressure at her home and was immediately rushed to a private hospital in Hyderabad. Despite the best efforts of the medical team, she was declared brain dead on July 16.

Faced with an agonizing decision, her son, Mani Chandra, chose to honor his mother’s legacy of care by consenting to organ donation. Thanks to his heartbreaking yet heroic choice, Seethamma’s kidneys, liver, and corneas were successfully harvested, giving a second chance at life to five patients desperately waiting for transplants.

The Second Hero: A Driver’s Legacy of Service

In a parallel story of profound generosity, 56-year-old Namala Sahadev, a dedicated driver from Bowrampet in the Medchal-Malkajgiri district, also became an unsung hero. On July 3, Sahadev suffered a severe hemorrhagic stroke (cerebrovascular accident) at home due to uncontrolled hypertension.

Despite intensive care unit (ICU) support, his condition did not improve, and he too was declared brain dead on July 16. In a moment of immense strength and compassion, his wife, Namala Laxmi, gave her consent to donate his kidney and liver. Her selfless decision directly saved the lives of two more patients in critical need.

The Ripple Effect of Compassion

Together, these two families have orchestrated a medical miracle. By choosing to look beyond their own profound sorrow, they have rewritten the destinies of seven individuals and their families.

Organ donation in India, particularly in the Telangana and Andhra Pradesh regions, has seen a steady and encouraging rise, driven by growing awareness and the courageous decisions of families just like Seethamma’s and Sahadev’s. Their actions highlight the critical role of private hospitals and transplant coordinators in facilitating these delicate, time-sensitive procedures with the utmost respect and dignity.

Looking Ahead: A Call to Action

The stories of Burela Seethamma and Namala Sahadev are not just news headlines; they are powerful calls to action. They challenge us to have open conversations with our loved ones about organ donation and to consider registering as donors ourselves.

Every year, thousands of patients wait in vain for a life-saving transplant. By choosing to donate, we can turn tragedy into triumph, ensuring that our legacy lives on in the beating hearts and seeing eyes of others. To the families of Guntur and Medchal: your extraordinary generosity will forever be remembered, and the seven lives you saved are your greatest testament.

Early Detection Saves Lives | Free Cancer Screening Camp in Hyderabad | 26 June 2026

    Cancer doesn’t wait, and neither should you. In the fight against cancer, early detection is the most powerful weapon we have. That’s why the Rotary Club of Greater Hyderabad, in association with the Basavatarakam Indo-American Cancer Hospital & Research Institute, is organizing a Cancer Awareness & Screening Camp – and it’s an event you won’t want to miss.

    Event Highlights

    • Date: Friday, 26th June 2026
    • Venue: Praneeth Pranav Knight Woods, Beeramguda, Ramachandra Puram – BHEL, Hyderabad
    • Open to: All Rotary members, staff, and their families

    What’s Available at the Camp?

    This camp is designed to make cancer screening simple, accessible, and actionable. Services include:

    • Breast Cancer Screening
    • Lung Check‑up
    • Comprehensive Cancer Tests
    • Doctor Consultation (on‑site)

    Why You Should Attend

    Many cancers are treatable when caught early. This camp removes the excuses – no long waits, no complicated appointments. Just show up, get screened, and take the first step toward better protection and a healthier life.

    “Early Detection • Better Protection • Healthier Life”

    How to Reach the Venue

    The camp will be held at Praneeth Pranav Knight Woods in Beeramguda (near BHEL, Ramachandra Puram).
    📍 Scan the QR code on the poster to open the exact location on Google Maps – easy navigation, just scan & go.

    Final Word

    Whether you’re a Rotary member, staff, or family member, this camp is your opportunity to take charge of your health. Don’t wait for symptoms to appear. Be proactive. Get screened.

    Mark your calendar for 26th June 2026 – because one Friday morning could save your life.

    Doctors Unite to Support Hyderabad Paediatrician Amid Legal Threat Over ORS Advice

    A wave of support is building across the medical community for a Hyderabad-based paediatrician, Dr. Sivaranjani Santosh, who is facing legal notices from pharmaceutical companies over her long-standing campaign on misleading ORS (Oral Rehydration Solution) products.

    What Sparked the Controversy?

    For nearly a decade, Dr. Sivaranjani has been raising concerns about high-sugar beverages being marketed as ORS, arguing that such products can be harmful—especially for children.

    Recently, two pharmaceutical companies issued cease-and-desist notices, accusing her of making defamatory statements and demanding that she stop her public advocacy.

    The companies, however, maintain that their products comply with regulatory standards and are backed by scientific evidence.

    Medical Community Calls It “Intimidation”

    The legal action has triggered strong reactions from doctors and healthcare organizations across the country.

    Medical associations have described the notices as:

    • “Unwarranted”
    • An “attempt to intimidate” a doctor
    • A move that could silence public health advocacy

    Many professionals argue that raising concerns about patient safety should not lead to legal threats, especially when backed by scientific reasoning and regulatory discussions.

    Backed by Regulations and Public Support

    Dr. Sivaranjani has defended her stance, stating that her claims are aligned with Food Safety and Standards Authority of India (FSSAI) directives, which restrict the misuse of the term “ORS” for non-compliant products.

    Her years-long campaign even contributed to stricter regulations on labeling, highlighting the impact of sustained public health advocacy.

    Meanwhile, support has extended beyond the medical community, with:

    • Social media campaigns like #StandWithDrSivaranjani
    • Backing from parents and public health advocates

    A Bigger Debate: Public Health vs Legal Pressure

    This issue has now grown into a broader debate about:

    • The role of doctors in public advocacy
    • Corporate accountability in healthcare
    • Whether legal notices can discourage professionals from speaking out

    For many, the case represents a critical moment for medical freedom and patient safety.

    Why This Matters

    At its core, the controversy is not just about one doctor—it’s about whether health professionals can openly challenge practices they believe may harm patients.

    As the debate continues, the strong support for Dr. Sivaranjani shows that the medical community is standing firm on one principle:
    👉 Patient safety should always come first.

    Taking Steps Against the ‘Silent Thief’: Glaucoma Awareness Walk in Hyderabad

    A Walk for Vision, A Step Towards Prevention

    Hyderabad, March 2026 — The early morning sun saw hundreds gather at the L.V. Prasad Eye Institute (LVPEI) Kallam Anji Reddy campus, not for a marathon, but for a cause that could save their sight. The annual Glaucoma Awareness Walk brought together approximately 300-600 participants, all united against a disease that steals vision without warning—glaucoma.

    The Silent Thief of Vision

    Glaucoma isn’t called the ‘Silent Thief of Vision’ for nothing. It creeps in without symptoms, without pain, and by the time you notice something’s wrong, irreversible damage has already been done. The statistics are staggering:

    • 1.12 crore Indians suffer from glaucoma
    • 11 lakh people in India are already blind due to this condition
    • 80 million people worldwide are affected
    • 90% of cases go undetected until it’s too late

    What’s more terrifying? Once lost, vision cannot be restored.

    Voices of Authority

    V.C. Sajjanar, Managing Director of Telangana State Road Transport Corporation (TSRTC) and former ADGP, graced the event as chief guest. He emphasized the critical need for early detection and announced TSRTC’s commitment to spreading awareness at bus stands and inside buses across the state.

    “Over 10 million people in India suffer from glaucoma, often without realising it,” Sajjanar noted, urging everyone to prioritize regular comprehensive eye examinations.

    Expert Warnings & Key Insights

    Dr. Sirisha Senthil, Head of Glaucoma Services at LVPEI, painted a sobering picture. Glaucoma affects one in eight people aged over 40, but it doesn’t spare the young either. Newborns in consanguineous marriages face heightened risks—a telltale sign being when the black part of the eye turns white or blue.

    Another silent culprit? Steroid misuse. Over-the-counter steroid medications, used without medical supervision, can trigger glaucoma and cause permanent vision damage.

    Dr. Siddharth Dixit, Consultant Ophthalmologist at LVPEI, drove home the message: “Please get comprehensive eye checkups done at regular intervals. Do not miss the tests, especially if you have a family history of glaucoma.”

    The Good News: Preventable Blindness

    Here’s what makes glaucoma different from other blinding diseases—80% of glaucoma-related blindness is preventable if detected and treated early. Most patients with glaucoma can lead productive, fulfilling lives throughout, provided they follow their treatment plan and don’t miss check-ups.

    Who Should Get Checked?

    According to the World Glaucoma Association:

    • Under 40: Every 2-4 years
    • 40-60 years: Every 2-3 years
    • Above 60: Every 1-2 years

    High-risk groups include those with high myopia (thick glasses), diabetics, long-term steroid users, and anyone with a family history of glaucoma.

    More Than Just a Walk

    The Glaucoma Awareness Walk wasn’t an isolated event—it capped off World Glaucoma Week (March 8-16), which featured social media campaigns, practitioner workshops, and continuous medical education sessions across the LVPEI network. A flash mob at KBR Park entrance pulled in morning walkers, ensuring the message reached beyond the registered participants.

    The Message is Simple

    Glaucoma is not a reason to lose hope. With regular check-ups, proper medication, and timely intervention, you can protect your vision. The question isn’t whether you can afford to get checked—it’s whether you can afford not to.

    Your eyes are your window to the world. Don’t let the silent thief close the curtains.

    Hyderabad Police ‘Arrive Alive’ Road Safety Program Draws Over 600 Participants

    The Hyderabad City Police on Wednesday, January 28, organised ‘Arrive Alive’, a road safety awareness programme, at the APJ Abdul Kalam Auditorium in Ibrahim Bagh. The event was held in collaboration with Vasavi Engineering College and was attended by over 600 students and faculty members.

    Addressing the gathering, Joint Commissioner of Police Joel Davis said the Arrive Alive movement was launched by Telangana Director General of Police B. Shivadhar Reddy with the aim of ensuring that road safety awareness reaches every household and institution across the State.

    Highlighting the alarming rise in road accidents, Davis said nearly 8,000 people lost their lives in road accidents in Telangana last year, adding that 70–80 per cent of these fatalities were preventable had basic safety precautions been followed. He also underlined the severe socio-economic impact road accidents have on families.

    Speaking about the Good Samaritan Act, Davis explained that bystanders who assist accident victims are not required to disclose personal details or phone numbers and will not be compelled by police to act as witnesses. He added that private hospitals are legally mandated to provide immediate treatment during the ‘golden hour’, and noted that the government is exploring reward mechanisms through the Transport Department for individuals who help save lives.

    Deputy Commissioner of Police (Traffic) Rahul Hegde said roads are shared public spaces and traffic rules are designed to ensure safety and equal access for all citizens. He urged students to behave responsibly on roads and to act as ambassadors of road safety in society.

    Sri Nityananda Trayodashi – 31st January 2026 (Saturday)

    ✨ Divine Appearance Day Celebration ✨

    Bhaktivedanta Institute, Hyderabad
    cordially invites all devotees and well-wishers to celebrate the auspicious Sri Nityananda Trayodashi, marking the divine appearance of Sri Nityananda Prabhu, the embodiment of mercy, compassion, and pure devotional love.

    📍 Venue:
    Marri Krishna Hall,
    Near Dr. M. Channa Reddy Garu’s Residence &
    St. Ann’s High School, Vijayapuri Colony,
    Tarnaka, Secunderabad

    🕉️ Program Schedule:
    🕘 9:00 AM – 9:30 AM: Kirtan
    🕤 9:30 AM – 10:30 AM: Abhishekam
    🕥 10:30 AM – 11:30 AM:
    Sri Nityananda Mahaprabhu Katha
    🕦 11:30 AM: Aarti
    🍛 Followed by Mahaprasadam

    🌼 Come and receive the blessings of Sri Nityananda Prabhu, the original spiritual master who bestows pure love of God.

    📞 Contact:
    +91 94901 38389 | +91 94414 91855

    🙏 All are cordially invited.